# The STAR™ Tumor Ablation Registry

> **NCT02419703** · — · TERMINATED · sponsor: **Merit Medical Systems, Inc.** · enrollment: 65 (actual)

## Conditions studied

- Metastatic Lesions in Vertebral Bodies

## Interventions

- **DEVICE:** STAR™ Tumor Ablation System

## Key facts

- **NCT ID:** NCT02419703
- **Lead sponsor:** Merit Medical Systems, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2015-10
- **Primary completion:** 2017-03-20
- **Final completion:** 2017-03-20
- **Target enrollment:** 65 (ACTUAL)
- **Why stopped:** Difficulty Enrolling
- **Last updated:** 2017-04-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02419703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02419703, "The STAR™ Tumor Ablation Registry". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02419703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*